Jan 5, 2021 by Jason HawthorneHow MRNA Stock Performed in 2020Shareholders were rewarded for holding through volatility.
Jan 5, 2021 by Jason Hawthorne3 Things to Expect From Teladoc in 2021Can the telehealth leader keep its growth surge going?
Jan 5, 2021 by Jason HawthorneWall Street Has Given Up on These 3 Stocks, and That's a Huge MistakeConsistent performance is often overlooked by short-term traders.
Jan 5, 2021 by Jason HawthorneCould Johnson & Johnson Be a Millionaire-Maker Stock?New sources of growth are needed if the stock is going to beat the market.
Jan 4, 2021 by Jason HawthorneThe Worst Mistake Novavax Investors Can Make Right NowInvestors will soon have data to judge management's big projections.
Jan 4, 2021 by Jason HawthorneThe Worst Mistake Moderna Investors Can Make Right NowThe COVID-19 vaccine could be the first of a long list of successes.
Jan 4, 2021 by Jason HawthorneThe Worst Mistake Trillium Investors Can Make Right NowThe company's long-term plan is to challenge conventional cancer therapy.
Jan 1, 2021 by Jason HawthorneWhy AT&T Is a Retiree's Dream StockThe dividend looks safe, and a new CEO has a plan to keep it that way.
Dec 31, 2020 by Jason Hawthorne3 High-Yield Stocks at Rock-Bottom PricesWasting shareholder money has put these three companies in Wall Street's doghouse.
Dec 31, 2020 by Jason Hawthorne2 of the Highest Growth Stocks in the Market TodayHelping the world cope with a pandemic increased sales by several multiples for these companies.
Dec 30, 2020 by Jason HawthorneGot $1,000? Buying These 3 Stocks Could Be the Smartest Move You Ever MadeGreat companies tend to outperform even lofty expectations over time.
Dec 28, 2020 by Jason Hawthorne2 Top Stocks for RetireesDividends are only part of the story for these two high-yielders.
Dec 23, 2020 by Jason HawthorneIs Johnson & Johnson Stock a Buy?The stock hasn't even beaten the S&P 500 over the past decade.
Dec 19, 2020 by Jason HawthorneGot $1,000? Here Are 3 Stocks to Consider Buying Right NowSolving customer problems is leading to rapid growth for these young tech companies.
Dec 19, 2020 by Jason Hawthorne3 Surefire Stocks on My Christmas Wish ListThese companies are defining their industries and rewarding shareholders.
Dec 19, 2020 by Jason HawthorneShould You Buy Sage Stock After the Biogen Investment?Each company has suffered a clinical failure recently, but this team-up could do good things for both.
Dec 19, 2020 by Jason HawthorneBetter Coronavirus Stock: Pfizer vs. BioNTechOne healthcare company is confident about its future while the other tries to recapture its former glory.
Dec 17, 2020 by Jason HawthorneDown 9% in 2020, Is Biogen Now a Buy?The company isn't standing still while its Alzheimer's drug is up in the air.
Dec 17, 2020 by Jason HawthorneIf You Invested $5,000 in Pfizer In January, Here's How Much You'd Have NowShares didn't benefit much from the pharma's efforts to help to save humanity.
Dec 17, 2020 by Jason HawthorneWhy Is Everyone Talking About Johnson & Johnson Stock?A potentially huge advantage for the company's vaccine will soon have everyone talking.
